Manulife (Manufacturers Life Insurance)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-46,724
| Closed | -$840K | – | 2974 |
|
|
2020
Q2 | $840K | Sell |
46,724
-2,158
| -4% | -$30K | ﹤0.01% | 1703 |
|
|
2020
Q1 | $349K | Buy |
48,882
+4,162
| +9% | +$51.9K | ﹤0.01% | 2010 |
|
|
2019
Q4 | $1.07M | Sell |
44,720
-361
| -0.8% | -$9.96K | ﹤0.01% | 1644 |
|
|
2019
Q3 | $1.21M | Buy |
45,081
+3,461
| +8% | +$97.2K | ﹤0.01% | 1559 |
|
|
2019
Q2 | $1.13M | Sell |
41,620
-1,046
| -2% | -$32.8K | ﹤0.01% | 1586 |
|
|
2019
Q1 | $1.48M | Buy |
42,666
+1,796
| +4% | +$51.8K | ﹤0.01% | 1514 |
|
|
2018
Q4 | $798K | Sell |
40,870
-1,617
| -4% | -$33.3K | ﹤0.01% | 1691 |
|
|
2018
Q3 | $1.13M | Sell |
42,487
-5,714
| -12% | -$187K | ﹤0.01% | 1721 |
|
|
2018
Q2 | $1.82M | Buy |
48,201
+5,652
| +13% | +$216K | ﹤0.01% | 1531 |
|
|
2018
Q1 | $1.39M | Sell |
42,549
-811
| -2% | -$35.6K | ﹤0.01% | 1654 |
|
|
2017
Q4 | $2.11M | Buy |
43,360
+1,460
| +3% | +$73.8K | ﹤0.01% | 1467 |
|
|
2017
Q3 | $2.26M | Buy |
41,900
+3,288
| +9% | +$193K | ﹤0.01% | 1393 |
|
|
2017
Q2 | $2.17M | Sell |
38,612
-127
| -0.3% | -$5.09K | ﹤0.01% | 1421 |
|
|
2017
Q1 | $1.52M | Buy |
38,739
+4,440
| +13% | +$141K | ﹤0.01% | 1538 |
|
|
2016
Q4 | $769K | Buy |
34,299
+249
| +0.7% | +$4.86K | ﹤0.01% | 1811 |
|
|
2016
Q3 | $774K | Buy |
34,050
+121
| +0.4% | +$2.84K | ﹤0.01% | 1798 |
|
|
2016
Q2 | $801K | Buy |
33,929
+1,002
| +3% | +$24.7K | ﹤0.01% | 1741 |
|
|
2016
Q1 | $665K | Buy |
32,927
+2,466
| +8% | +$78.2K | ﹤0.01% | 1816 |
|
|
2015
Q4 | $1.57K | Buy |
30,461
+303
| +1% | +$14.7K | ﹤0.01% | 1454 |
|
|
2015
Q3 | $1.28K | Buy |
30,158
+795
| +3% | +$38.4K | ﹤0.01% | 1490 |
|
|
2015
Q2 | $1.34K | Buy |
29,363
+1,517
| +5% | +$61K | ﹤0.01% | 1532 |
|
|
2015
Q1 | $1.06K | Buy |
27,846
+1,048
| +4% | +$36K | ﹤0.01% | 1654 |
|
|
2014
Q4 | $759 | Buy |
26,798
+2,874
| +12% | +$79.9K | ﹤0.01% | 1743 |
|
|
2014
Q3 | $605 | Buy |
23,924
+493
| +2% | +$13K | ﹤0.01% | 1871 |
|
|
2014
Q2 | $684K | Buy |
23,431
+14,429
| +160% | +$349K | ﹤0.01% | 1828 |
|
|
2014
Q1 | $233 | Buy |
9,002
+75
| +0.8% | +$2K | ﹤0.01% | 2614 |
|
|
2013
Q4 | $230 | Buy |
8,927
+1,399
| +19% | +$34K | ﹤0.01% | 2612 |
|
|
2013
Q3 | $201 | Buy |
+7,528
| New | +$179K | ﹤0.01% | 2655 |
|
Manulife (Manufacturers Life Insurance)'s PTLA Position: Q3 2020 in Review
Manulife (Manufacturers Life Insurance) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 46,724 shares — an estimated $840K sold.
Manulife (Manufacturers Life Insurance) first reported a position in PTLA in Q3 2013 and held it in 28 quarters. The position peaked at $2.26M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Manulife (Manufacturers Life Insurance) reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 46,724 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $840K.
- Manulife (Manufacturers Life Insurance) first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and held it in 28 quarters.
- Manulife (Manufacturers Life Insurance)'s Portola Pharmaceuticals, Inc. position peaked at $2.26M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2020, filed 9 Nov 2020.